RNAC (Cartesian Therapeutics) Kacepetan wutah bathi saben saham ing taun lumaku

Lambang korporat lan logo Selecta Biosciences Inc. (RNAC)

Cartesian Therapeutics (RNAC) is developing advanced RNA therapies for cancer and autoimmune pathologies while awaiting breakthrough clinical data. The annual earnings per share trend, where the value of 56.30 expresses the metric level, links these achievements to a unique gene-editing platform that is attractive to pharma behemoths. In the future, positive trial results will enable the company to establish premium rates for insurance organizations.

RNAC: Wutah bathi saben saham ing taun lumaku Selecta Biosciences 21.02.2024 - 10.11.2026

Rincian metrik keuangan lan pasar Cartesian Therapeutics (RNAC)

- rega lan prakiraan konsensus rega:
Kutipan saham Selecta Biosciences|RNAC - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Nilai pasar Selecta Biosciences Inc.|RNAC - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Aset Bersih saben Siji Saham Cartesian Therapeutics|RNAC - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku selectabio.com|RNAC - Gunggung Aset Perusahaan
- rincian utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Cartesian Therapeutics|RNAC - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas selectabio.com|RNAC - Gunggung utang perusahaan|Utang-utang marang nilai buku Selecta Biosciences Inc.|RNAC - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Cartesian Therapeutics|Likuiditas darurat selectabio.com
- informasi bathi lan kelipatan valuasi:
RNAC - Penghasilan resik|Penghasilan resik sing dikarepake Cartesian Therapeutics|RNAC - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Selecta Biosciences Inc.|RNAC - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Selecta Biosciences Inc.|RNAC - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Cartesian Therapeutics|RNAC - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan selectabio.com|RNAC - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Cartesian Therapeutics
Pambiji fundamental:RNAC Selecta Biosciences
Produk sing diprodhuksi Cartesian Therapeutics

For mRNA therapy innovator Cartesian Therapeutics (RNAC), earnings per share dynamics reflect the monetization efficiency of advanced treatments for autoimmune pathologies. Comparing annual EPS growth measures the percentage deviation of current net income from the previous year's figures, allowing investors to assess the company's ability to scale scientific achievements into real financial stability and capitalization.

Pesaing utama

Wutah bathi resik saben saham ing taun iki Legend Biotech Corp|SANA (Sana Bio) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Autolus Corp AUTL|Wutah bathi saben saham ing taun lumaku Allogene Therapeutics (ALLO)|Wutah bathi saben saham ing taun lumaku CLLS (cellectis.com)|Wutah bathi saben saham ing taun lumaku Caribou Biosciences, Inc. CRBU|Instil Bio Inc. - Wutah bathi saben saham ing taun lumaku|GNTA: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku IPSC (Century Therapeutics)|JSPR: Wutah bathi ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku Senti Biosciences SNTI|ADAP (Adaptimmune Therapeutics plc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku CERo Therapeutics Holdings Inc. CERO|Wutah bathi saben saham ing taun lumaku Alaunos Therapeutics (TCRT)|achillestx.com - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku CRGX (CARGO Therapeutics)|poseida.com (PSTX) - Kacepetan wutah bathi saben saham ing taun lumaku|TSVT: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku GRCL (Gracell Bio)